References

  1. Organisation Mondiale de la Santé. Guide de prise en charge de la tuberculose. Kinshasa. 2008. Google Scholar

  2. Organisation Mondiale de la Santé. Plan mondial halte à la tuberculose 2011-2015. Geneva. 2010. Google Scholar

  3. Organisation Mondiale de la Santé. Rapport sur la lutte contre la tuberculose dans le monde. Geneva. 2011. Google Scholar

  4. Organisation Mondiale de la Santé. Rapport sur la santé dans le monde. Geneva. 1997. Google Scholar

  5. Ministère de la Santé. Plan stratégique 2006-201 Programme National de Lutte contre la Tuberculose. Kinshasa. 2006. Google Scholar

  6. Ministère de la Santé. Enquête de prévalence sur la résistance tuberculeuse dans la ville de Kinshasa. Programme National de Lutte contre la Tuberculose. Kinshasa, 1999. Google Scholar

  7. Organisation Mondiale de la Santé. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva. 2008. Google Scholar

  8. Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding (State of the art series, Drug-resistant tuberculosis, Edited by CY, Chiang, Number 4 in the series). Int J Tuberc Lung Dis. 2010; 14(4): 382-390. PubMed | Google Scholar

  9. Organisation Mondiale de la Santé. Interim recommendations for the surveillance of drug resistance in tuberculosis. Geneva. 2007. Google Scholar

  10. Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis. 2002; 6(10): 858-864. PubMed | Google Scholar

  11. Organisation Mondiale de la Santé. Global Tuberculosis Control- surveillance, planning, financing. Geneva. 2008. Google Scholar

  12. Organisation Mondiale de la Santé. The Global MDR-TB and XDR-TB Response Plan 2007-2008. Geneva. 2007. Google Scholar

  13. Organisation Mondiale de la Santé (2006). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs -worldwide, 2000-2004. Morb Mortal Wkly Rep. 2006; 55(11): 301-305. PubMed | Google Scholar

  14. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. The Lancet. 2006; 368 (9547): 1575-1580. PubMed | Google Scholar

  15. Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC. From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift. Tuberculosis. 2003; 83(13): 59-65. PubMed | Google Scholar

  16. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis (State of the art series, Drug-resistant tuberculosis, Edited by CY; Chiang; Number 1 in the series). Int J TubercLung Dis. 2009; 13(11): 1320-1330. PubMed | Google Scholar

  17. Organisation Mondiale de la Santé. Anti-tuberculosis drug resistance in the World. Geneva. 2008. Google Scholar

  18. Marahatta SB, Kaewkungwal J, Ramasoota P, Singhasivanon P. Risk factors of Multidrug Resistant Tuberculosis in central Nepal: A pilot study. Kathmandu Univ Med J. 2012; 8(4): 392-397. PubMed | Google Scholar

  19. Ahmad AM, Akhtar S, Hasan R, Khan JA, Hussain SF, Rizvi N. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study. Int J Mycobacteriol. 2012; 1(3): 137-142. PubMed | Google Scholar

  20. Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rüsch-Gerdes S, Gutiérrez J, Jarlier V. A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist. 2005; 11(1): 62-67. PubMed | Google Scholar

  21. Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, Rusovich V, Dadu A, De Colombani P, Dara M, Van Gemert W, Zignol M. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ. 2013; 91(1): 36-45. PubMed | Google Scholar

  22. Suárez-García I, Rodríguez-Blanco A, Vidal-Pérez JL, García-Viejo MA, Jaras-Hernández MJ, López O, Noguerado-Asensio A. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis. 2009; 28(4): 325-330. PubMed | Google Scholar

  23. Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC. Risk factors for multidrug-resistant tuberculosis in Hong Kong. IntJ Tuberc Lung Dis. 2008; 12(9): 1065-1070. PubMed | Google Scholar

  24. Organisation Mondiale de la Santé. Standards Internationaux pour le traitement de la tuberculose : Diagnostic, Traitement et Santé Publique. Geneva. 2006. Google Scholar

  25. Dabis F, Drucker J, Moren A. Épidémiologie d'intervention: aspects particuliers de la pratique de l'épidémiologie. Notes de cours ; Université Bordeaux Segalen. 2009. Google Scholar

  26. Bercion R, Kuaban C, Bercion R, Kuaban C. Résistance Initiale aux antituberculeux à Yaoundé, Cameroun, en 1995. Int J Tuberc Lung Dis. 1997; 1(2): 110-114. PubMed | Google Scholar

  27. Organisation Mondiale de la Santé. Principes directeurs à l'intention des programmes antituberculeux pour la prise en charge des tuberculoses pharmaco résistantes. Geneva. 2008. Google Scholar